MedPath
NMPA Approval

Lamivudine Tablets

国药准字HJ20171228

August 31, 2022

H20171228

Drug Information

拉米夫定片

益平维

片剂

0.3g

化学药品

August 31, 2022

August 30, 2027

Company Information

Applicant Company

ViiV Healthcare BV

Van Asch van Wijckstraat 55H, 3811 LP Amersfoort, The Netherlands

Manufacturing Company

delpharm poznan s.a

ul.Grunwaldzka 189, Poznan 60-322, Poland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉米夫定片 - NMPA 批准文号 | MedPath